| __timestamp | Neurocrine Biosciences, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 14400000 | 60987000 |
| Thursday, January 1, 2015 | 33800000 | 125542000 |
| Friday, January 1, 2016 | 35900000 | 210460000 |
| Sunday, January 1, 2017 | 1254000 | 275119000 |
| Monday, January 1, 2018 | 4889000 | 409539000 |
| Tuesday, January 1, 2019 | 7400000 | 547758000 |
| Wednesday, January 1, 2020 | 10100000 | 736300000 |
| Friday, January 1, 2021 | 14300000 | 904200000 |
| Saturday, January 1, 2022 | 23200000 | 1080300000 |
| Sunday, January 1, 2023 | 39700000 | 1262200000 |
| Monday, January 1, 2024 | 34000000 | 1530500000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, understanding cost structures is crucial for investors and stakeholders. Over the past decade, Vertex Pharmaceuticals Incorporated and Neurocrine Biosciences, Inc. have shown distinct trajectories in their cost of revenue. From 2014 to 2023, Vertex Pharmaceuticals experienced a staggering increase of over 1,900% in its cost of revenue, reflecting its aggressive expansion and scaling of operations. In contrast, Neurocrine Biosciences saw a more modest rise of approximately 175%, indicating a more stable growth pattern.
These insights provide a window into the strategic priorities and operational efficiencies of these biotech giants.
Cost of Revenue Trends: Johnson & Johnson vs Neurocrine Biosciences, Inc.
Novartis AG vs Neurocrine Biosciences, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pfizer Inc. vs Neurocrine Biosciences, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down GSK plc and Neurocrine Biosciences, Inc.'s Expenses
Takeda Pharmaceutical Company Limited vs Neurocrine Biosciences, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs Halozyme Therapeutics, Inc.
Analyzing Cost of Revenue: Neurocrine Biosciences, Inc. and PTC Therapeutics, Inc.
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs HUTCHMED (China) Limited